Allianz Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.37M Buy
8,100
+3,100
+62% +$1.02M ﹤0.01% 1496
2025
Q4
$1.75M Sell
5,000
-2,700
-35% -$912K ﹤0.01% 1593
2025
Q3
$2.49M Sell
7,700
-4,100
-35% -$1.28M ﹤0.01% 1412
2025
Q2
$4.59M Buy
11,800
+7,900
+203% +$3.18M 0.01% 1151
2025
Q1
$1.7M Sell
3,900
-2,800
-42% -$1.12M ﹤0.01% 1530
2024
Q4
$2.47M Buy
6,700
+5,500
+458% +$2.3M ﹤0.01% 1346
2024
Q3
$624K Buy
1,200
+1,000
+500% +$534K ﹤0.01% 1790
2024
Q2
$108K Sell
200
-2,100
-91% -$1.11M ﹤0.01% 2054
2024
Q1
$1.19M Sell
2,300
-7,300
-76% -$3.63M ﹤0.01% 1363
2023
Q4
$4.53M Sell
9,600
-7,900
-45% -$3.65M 0.01% 961
2023
Q3
$7.62M Buy
17,500
+3,600
+26% +$1.63M 0.01% 821
2023
Q2
$6.18K Buy
13,900
+2,300
+20% +$1.06M ﹤0.01% 1972
2023
Q1
$5.33M Buy
11,600
+700
+6% +$333K 0.01% 944
2022
Q4
$5.59M Buy
10,900
+2,800
+35% +$1.42M 0.01% 875
2022
Q3
$3.68M Buy
8,100
+6,900
+575% +$3.3M 0.01% 1008
2022
Q2
$579K Sell
1,200
-8,100
-87% -$4.01M ﹤0.01% 1853
2022
Q1
$4.57M Buy
9,300
+400
+4% +$183K ﹤0.01% 1262
2021
Q4
$4.13M Sell
8,900
-3,400
-28% -$1.43M ﹤0.01% 1308
2021
Q3
$4.58M Buy
12,300
+7,800
+173% +$2.96M ﹤0.01% 1315
2021
Q2
$1.72M Sell
4,500
-200
-4% -$76.4K ﹤0.01% 1525
2021
Q1
$1.69M Buy
+4,700
New +$1.51M ﹤0.01% 1469
2020
Q3
Sell
-31,300
Closed -$8.23M 2024
2020
Q2
$8.23M Buy
31,300
+7,600
+32% +$2.03M 0.01% 978
2020
Q1
$5.38M Sell
23,700
-59,100
-71% -$16.1M 0.01% 1136
2019
Q4
$25M Buy
82,800
+7,100
+9% +$1.95M 0.02% 688
2019
Q3
$18.2M Buy
75,700
+9,700
+15% +$2.66M 0.02% 812
2019
Q2
$18.6M Buy
66,000
+18,800
+40% +$5.14M 0.02% 844
2019
Q1
$13.5M Sell
47,200
-48,500
-51% -$14M 0.01% 970
2018
Q4
$25.1M Sell
95,700
-21,200
-18% -$5.83M 0.03% 606
2018
Q3
$32M Sell
116,900
-24,000
-17% -$6.23M 0.03% 619
2018
Q2
$33.5M Buy
140,900
+7,000
+5% +$1.62M 0.03% 583
2018
Q1
$29.4M Sell
133,900
-514,100
-79% -$121M 0.03% 661
2017
Q4
$146M Buy
648,000
+34,400
+6% +$7.33M 0.11% 201
2017
Q3
$117M Buy
613,600
+178,800
+41% +$34M 0.1% 241
2017
Q2
$81.8M Buy
434,800
+22,100
+5% +$3.97M 0.08% 298
2017
Q1
$68.3M Sell
412,700
-159,800
-28% -$25.4M 0.07% 354
2016
Q4
$82.3M Buy
572,500
+304,500
+114% +$40.8M 0.07% 332
2016
Q3
$33.6M Sell
268,000
-15,500
-5% -$2M 0.03% 678
2016
Q2
$37.2M Buy
283,500
+133,400
+89% +$18.3M 0.04% 556
2016
Q1
$20.9M Buy
150,100
+20,400
+16% +$2.73M 0.02% 765
2015
Q4
$18.1M Buy
129,700
+42,300
+48% +$5.83M 0.02% 801
2015
Q3
$12.2M Sell
87,400
-40,600
-32% -$6.1M 0.01% 905
2015
Q2
$21M Buy
128,000
+26,100
+26% +$4.17M 0.02% 758
2015
Q1
$15.7M Buy
101,900
+4,700
+5% +$669K 0.02% 775
2014
Q4
$12.2M Buy
97,200
+56,600
+139% +$6.99M 0.01% 879
2014
Q3
$4.86M Buy
+40,600
New +$4.66M 0.01% 1079

Other funds holding ELV

Allianz Asset Management's ELV Position: Q1 2026 in Review

Allianz Asset Management increased its Elevance Health (ELV) stake by 29% in Q1 2026, buying an estimated $39.7M and bringing the position to 535,894 shares worth $157M. The position accounts for 0.16% of the portfolio, ranked #119.

Allianz Asset Management first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $548M in Q1 2015. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Allianz Asset Management held 535,894 shares of Elevance Health worth $157M as of Q1 2026.
  • Allianz Asset Management bought 120,821 Elevance Health shares in Q1 2026, an estimated $39.7M.
  • Elevance Health made up 0.16% of Allianz Asset Management's portfolio in Q1 2026, its #119 holding.
  • Allianz Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • Allianz Asset Management's Elevance Health position peaked at $548M in Q1 2015.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.